These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2514623)

  • 1. Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
    Celesk RA; Robillard NJ
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1921-6. PubMed ID: 2514623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.
    Robillard NJ; Scarpa AL
    Antimicrob Agents Chemother; 1988 Apr; 32(4):535-9. PubMed ID: 2837141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.
    Bedard J; Chamberland S; Wong S; Schollaardt T; Bryan LE
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1457-64. PubMed ID: 2510591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.
    Masecar BL; Celesk RA; Robillard NJ
    Antimicrob Agents Chemother; 1990 Feb; 34(2):281-6. PubMed ID: 2158277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium.
    Giraud E; Cloeckaert A; Kerboeuf D; Chaslus-Dancla E
    Antimicrob Agents Chemother; 2000 May; 44(5):1223-8. PubMed ID: 10770755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin.
    Legakis NJ; Tzouvelekis LS; Makris A; Kotsifaki H
    Antimicrob Agents Chemother; 1989 Jan; 33(1):124-7. PubMed ID: 2496655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo selection of a target/efflux double mutant of Pseudomonas aeruginosa by ciprofloxacin therapy.
    Le Thomas I; Couetdic G; Clermont O; Brahimi N; Plésiat P; Bingen E
    J Antimicrob Chemother; 2001 Oct; 48(4):553-5. PubMed ID: 11581237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of Pseudomonas aeruginosa biofilms in intrinsic drug resistance.
    Xie Y; Jia WX; Zeng W; Yang WQ; Cheng X; Li XR; Wang LL; Kang M; Zhang ZR
    Chin Med J (Engl); 2005 Oct; 118(19):1615-22. PubMed ID: 16232346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of continuous exposure to ciprofloxacin on the outer membrane of P. aeruginosa.
    Magni A; Giordano A; Papa F; de Vito D; Cipriani P
    New Microbiol; 1994 Oct; 17(4):307-12. PubMed ID: 7861986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant
    Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F; Manfreda G
    Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa.
    Michéa-Hamzehpour M; Furet YX; Pechère JC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2091-7. PubMed ID: 1662023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.
    Mouneimné H; Robert J; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 1999 Jan; 43(1):62-6. PubMed ID: 9869566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-Time Monitoring of
    Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa.
    Hamzehpour MM; Pechere JC; Plesiat P; Köhler T
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2392-6. PubMed ID: 8585714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ofloxacin-resistant Pseudomonas aeruginosa mutants with elevated drug extrusion across the inner membrane.
    Lei Y; Sato K; Nakae T
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1043-8. PubMed ID: 1651710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa develops Ciprofloxacin resistance from low to high level with distinctive proteome changes.
    Peng J; Cao J; Ng FM; Hill J
    J Proteomics; 2017 Jan; 152():75-87. PubMed ID: 27771372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa deficient in 8-oxodeoxyguanine repair system shows a high frequency of resistance to ciprofloxacin.
    Morero NR; Argaraña CE
    FEMS Microbiol Lett; 2009 Jan; 290(2):217-26. PubMed ID: 19025574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin binding to GyrA causes global changes in the proteome of Pseudomonas aeruginosa.
    Jedrey H; Lilley KS; Welch M
    FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29846552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.